美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

GSK plc ADRhedged

66.87

-0.3156-0.47%

成交量：103

成交额：6,887.76

市值：66.88万

市盈率：- -

高：66.87

开：66.87

低：66.87

收：67.19

52周最高：85.03

52周最低：61.00

股本：1.00万

流通股本：1.00万

量比：3.67

换手率：1.03%

股息：2.08

股息率：3.10%

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

重磅ADC药物获批多发性骨髓瘤二线联合用药，GSK中国特药业务部负责人：肿瘤是未来GSK重要增长引擎之一

流行病诊疗板块多股扬升雅培(ABT)涨1.60%、强生(JNJ)涨1.12%

中国生物制药涨超4%：牵手GSK合作乙肝临床治愈明星产品

正大天晴牵手GSK，瞄准乙肝百亿美元赛道商业化棋局

21世纪经济报道

中国生物制药牵手葛兰素史克布局乙肝新药在华商业化

时安生物与GSK就寡核苷酸新药达成超10亿美元授权合作；莎普爱思终止购买上海勤礼实业100%股权｜医药早参

每日经济新闻

葛兰素史克(GSK)股票4月29日盘中下跌5.22%：关键驱动因素揭晓

TradingKey中文

英国头部药企利润意外大增，尽管行业受美国政策冲击

环球市场播报

葛兰素史克Q1业绩超市场预期，预计全年盈利增长7%至9%

老虎资讯综合

从“抗艾第一股”到小核酸新贵前沿生物股价与业绩齐飞靠GSK千万美元授权金逆势涨停

葛兰素史克(GSK.US)Belantamab mafodotin(玛贝兰妥单抗)在华获批上市

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/GSKH/news?page=5"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":66.87,"timestamp":1791900249587,"preClose":67.1856,"halted":0,"volume":103,"delay":0,"changeRate":-0.0046974351646779855,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"交易中","change":-0.3156,"latestTime":"10-13 10:18:06 EDT","open":66.87,"high":66.87,"low":66.87,"amount":6887.76038,"amplitude":0,"askPrice":66.3,"askSize":100,"bidPrice":66.19,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1791921600000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":67.1856,"nav":66.281474,"aum":662881.021474,"dividendRate":0.031045,"bidAskSpread":0,"volumeRatio":3.666352,"impliedVol":0.3657,"impliedVolPercentile":0.9852},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":3.666352,"shares":10001,"dividePrice":2.076,"high":66.87,"amplitude":0,"preClose":67.1856,"low":66.87,"week52Low":61,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":66.87,"eps":0,"divideRate":0.031045,"volume":103,"delay":0,"ttmEps":0,"open":66.87,"prevYearClose":68.2031,"prevWeekClose":66.2858,"prevMonthClose":68.5811,"prevQuarterClose":68.5811,"fiveDayClose":66.2709,"twentyDayClose":69.7885,"sixtyDayClose":69.5661},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2636356678","title":"重磅ADC药物获批多发性骨髓瘤二线联合用药，GSK中国特药业务部负责人：肿瘤是未来GSK重要增长引擎之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2636356678","media":"蓝鲸财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636356678?lang=zh_cn&edition=fundamental","pubTime":"2026-05-19 15:41","pubTimestamp":1779176518,"startTime":"0","endTime":"0","summary":"值得注意的是，倍乐锐是GSK肿瘤领域的重磅药物。据GSK全球一季度财报，该药物在今年一季度收入达2300万英镑，在该款药物的加持下，肿瘤业务也已经是GSK当前业绩增长最快的板块。今年第一季度，GSK肿瘤业务销售额同比增长28%，达到5.12亿英镑，业务增速在所有业务中位居第一。GSK副总裁、中国特药业务部负责人张宁向蓝鲸新闻表示，GSK未来会考虑布局更多的ADC药物、小分子药物等形成合力，包括肿瘤在内的特药业务是未来GSK很重要的增长引擎之一。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1779176429659930072","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4588","ADC","BK4585","LU1829250122.USD","BK4532","BK4080","GSK","GSKH","BK4007","BK4231","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634101862","title":"流行病诊疗板块多股扬升 雅培(ABT)涨1.60%、强生(JNJ)涨1.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634101862","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634101862?lang=zh_cn&edition=fundamental","pubTime":"2026-05-12 22:05","pubTimestamp":1778594751,"startTime":"0","endTime":"0","summary":"金吾财讯 | 汉坦病毒疫情叠加药企药物研发/合作进展向好消息提振，美股流行病诊疗板块多股扬升，截至发稿，葛兰素史克  涨 1.93%，雅培  涨 1.60%，默沙东  涨 1.41%，阿斯利康  涨 1.18%，强生  涨 1.12%。达歌生物周二宣布与默沙东研发(中国)有限公司签署合作协议，共同推进抗肿瘤药物临床合作开发。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250107/MzZmY2I0ODMyNDljNDZhYjk1YmMwYzA2ZTYzZmI3NWMyMTczNjIzMDYxMjY4Mg==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MzZmY2I0ODMyNDljNDZhYjk1YmMwYzA2ZTYzZmI3NWMyMTczNjIzMDYxMjY4Mg==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"300341","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B42XCP33.USD","LU1989763690.USD","LU2237443622.USD","SG9999001176.USD","LU2089984988.USD","LU0859254822.USD","LU1989763427.SGD","LU2129689605.HKD","LU2491049909.HKD","SG9999014542.SGD","LU2602419157.SGD","LU1037948541.HKD","LU0124676726.USD","IE00B19Z3581.USD","LU0792757196.USD","LU1032955483.USD","IE00B4R5TH58.HKD","LU0545562505.USD","LU1196500208.SGD","LU1674673428.USD","IE00B7SZLL34.SGD","LU1699723380.USD","LU2468319806.SGD","BK4534","LU1244550577.SGD","IE000BZT7R73.USD","LU0058720904.USD","LU1291159041.SGD","LU0210528500.USD","LU1721429402.USD","LU1721429741.USD","LU1894683264.USD","LU2023250504.SGD","LU2505996681.GBP","LU1571399168.USD","LU1066053197.SGD","IE0034235303.USD","LU1043141396.HKD","BK4581","LU2023250330.USD","IE00BDGV0183.EUR","LU1228905540.USD","LU1934455194.USD","LU1037948897.HKD","LU1228905037.USD","LU2133065610.SGD","SG9999014559.SGD","LU0345769631.USD","LU0266013472.USD","LU0345769128.USD","LU0820561909.HKD","IE00BFXG1179.USD","LU2430703095.HKD","LU0070217475.USD","LU1914381329.SGD","LU1983299246.USD","LU0211331839.USD","LU0965508806.USD","BK4568","LU2125154778.USD","LU0689472784.USD","LU1267930813.SGD","LU2471134879.HKD","LU1066051498.USD","LU2750360641.GBP","LU0345770308.USD","LU2491050071.SGD","IE000WAW04H5.SGD","BK4504","LU1732800096.USD","LU0320765646.SGD","LU0683600562.USD","JNJ","BK4082","AZN","LU0477156953.USD","LU0965509283.SGD","LU1201861249.SGD","LU1941712264.USD","SGXZ41872573.SGD","SGXZ57979304.SGD","IE0000B7K699.USD","LU0114720955.EUR","LU1059921491.USD","SG9999002224.SGD","BK4592","LU2361045086.USD","LU0795875086.SGD","LU2756315664.SGD","LU0882574055.USD","LU0426412945.USD","LU0320765992.SGD","LU0985320562.USD","LU1691799644.USD","LU2237443382.USD","LU2462157665.USD","LU0861579265.USD","LU0053666078.USD","LU1585245621.USD","LU2106854487.HKD","LU0994945656.USD","BK4588","LU0943347566.SGD","LU1551013425.SGD","IE0002141913.USD","LU0265550946.USD","LU0942090050.USD","LU1061106388.HKD","LU2361044865.SGD","LU0320765489.SGD","BK4516","LU2237443549.SGD","BK4550","LU1496350502.SGD","LU2112291526.USD","IE0009355771.USD","BK4585","LU0640476718.USD","LU0820562030.AUD","LU2237443895.HKD","LU2471134523.USD","LU1778281490.HKD","LU1244550221.USD","LU1069347547.HKD","LU0170899867.USD","IE00B3PB1722.GBP","LU2491050154.USD","IE00B3T34201.USD","IE00BKVL7J92.USD","IE00B1BXHZ80.USD","LU2347655156.SGD","LU0964807845.USD","SG9999001176.SGD","SG9999014575.USD","IE00BLSP4239.USD","LU0868494617.USD","LU1093756325.SGD","BK4007","IE00BJT1NW94.SGD","LU0234570918.USD","LU1506573853.SGD","LU1093756168.USD","LU0208291251.USD","IE00BLSP4452.SGD","LU2417539215.USD","LU1917777945.USD","LU1261432733.SGD","LU0098860793.USD","LU1043141123.HKD","LU1074936037.SGD","LU2505996509.AUD","LU0122379950.USD","SG9999013999.USD","LU1974910355.USD","GSK.UK","BK4559","LU1829250122.USD","SG9999015341.SGD","LU2471134796.USD","LU2592432038.USD","LU1551013342.USD","LU1732799900.SGD","LU2896262040.SGD","LU2324357040.USD","LU2461242641.AUD","SG9999015358.SGD","LU1023059063.AUD","LU1121112475.USD","LU0795875169.SGD","SG9999002232.USD","LU1221951046.USD","LU1244550494.USD","LU1145028129.USD","IE00BN8TJ469.HKD","LU2237443465.HKD","IE000SO60NU8.SGD","LU0980610538.SGD","LU2023250843.SGD","IE00BFTCPJ56.SGD","LU2357627491.SGD","IE00BJJMRZ35.SGD","LU2430703178.SGD","LU1066051811.HKD","LU0130102774.USD","LU0265550359.USD","LU0432979614.USD","LU0109394709.USD","LU2360032135.SGD","IE00BBT3K403.USD","LU2236285917.USD","GSKH","LU0345770993.USD","LU0965509010.AUD","LU1066051225.USD","LU2125154935.USD","IE00BGHQF631.EUR","IE00BVYPNW00.USD","LU0234572021.USD","LU1934455277.USD","IE00BZ1G4Q59.USD","LU0130517989.USD","LU1941712348.USD","LU2129689431.USD","LU2237443978.SGD","LU2361044949.HKD","MRK","ABT","IE000M9KFDE8.USD","LU1280957306.USD","BK4532","LU0912757837.SGD","LU1032466523.USD","LU2756315318.SGD","LU1116320737.USD","LU1989772840.SGD","IE00B19Z3B42.SGD","LU1221951129.SGD","LU2487616109.SGD","IE000MB6IJN5.SGD","LU1934455863.HKD","LU0203347892.USD","LU2129689514.USD","LU2211815571.USD","LU2750360997.AUD","IE00B2B36J28.USD","LU0868494708.USD","LU0466842654.USD","LU2430703251.USD","LU0203345920.USD","LU2403377893.USD","LU2237957811.SGD","GSK","LU0648001328.SGD","LU1989772923.USD","SG9999004303.SGD","LU1894683348.USD","LU1162221912.USD","LU0289739699.SGD","LU2471134952.CNY","LU1674673691.USD","LU1935042991.SGD","LU0238689110.USD","BK4566","IE0002270589.USD","LU0106261372.USD","LU1057294990.SGD","LU0889566641.SGD","AZNH","LU0820561818.USD","IE000F7OJYX1.SGD","LU1430594728.SGD","LU1629891620.HKD","LU0006306889.USD","IE0001KFT4U8.USD","LU0889565916.HKD","IE00BSNM7G36.USD","SG9999014567.USD","BK4533","IE00BVYPNV92.GBP","LU0210536198.USD","LU2237957902.USD","LU2456880835.USD","LU1929549753.HKD","LU0965509101.SGD","LU1989771016.USD","LU0426417589.USD","SGXZ23171101.USD","SG9999001440.SGD","LU0689626769.HKD","LU0787776722.HKD","LU2213496289.HKD","LU1035773651.USD","LU0070302665.USD","LU1718418525.SGD","LU1116320901.HKD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2634338289","title":"中国生物制药涨超4%：牵手GSK合作乙肝临床治愈明星产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2634338289","media":"澎湃新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634338289?lang=zh_cn&edition=fundamental","pubTime":"2026-05-11 19:58","pubTimestamp":1778500680,"startTime":"0","endTime":"0","summary":"全球首款有望最快实现乙肝功能性治愈的重磅药物被中国生物制药收入囊中！5月11日，中国生物制药（1177.HK）正式宣布，核心子公司正大天晴药业集团与知名跨国药企葛兰素史克（LSE/NYSE：GSK）达成独家战略合作，将加速一款名为bepirovirsen的药物在中国的上市进程。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605113733296932.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605113733296932.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["HK0000165453.HKD","IE00BZ08YR35.GBP","01177","BK1589","BK4532","BK4588","GSK","BK1515","BK1191","GSK.UK","GSKH","LU1829250122.USD","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK4585","BK4007","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634405436","title":"正大天晴牵手GSK，瞄准乙肝百亿美元赛道商业化棋局","url":"https://stock-news.laohu8.com/highlight/detail?id=2634405436","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634405436?lang=zh_cn&edition=fundamental","pubTime":"2026-05-11 15:26","pubTimestamp":1778484360,"startTime":"0","endTime":"0","summary":"中国乙肝治疗药物市场正在迎来一个关键变量。5月11日，中国生物制药（1177.HK）公告，其核心子公司正大天晴与葛兰素史克（GSK）就反义寡核苷酸（ASO）药物Bepirovirsen达成独家战略合作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605113733015888.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605113733015888.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GSK","LU1829250122.USD","GSKH","BK4532","GSK.UK","BK4585","BK4007","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634847134","title":"中国生物制药牵手葛兰素史克 布局乙肝新药在华商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2634847134","media":"财中社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634847134?lang=zh_cn&edition=fundamental","pubTime":"2026-05-11 12:34","pubTimestamp":1778474040,"startTime":"0","endTime":"0","summary":"5月11日，中国生物制药（01177）发布公告，附属公司正大天晴与葛兰素史克达成独家战略合作，加速bepirovirsen在中国内地的上市进程。根据协议，正大天晴将负责bepirovirsen在中国内地的进口、分销、医院准入以及推广和非推广活动，产生的全部销售收入将确认为正大天晴的营业收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605113732881024.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605113732881024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1829250122.USD","GSK.UK","BK4007","BK4532","01177","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK4585","BK1515","BK1589","HK0000165453.HKD","BK4588","BK1521","BK1191","GSKH","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633512166","title":"时安生物与GSK就寡核苷酸新药达成超10亿美元授权合作；莎普爱思终止购买上海勤礼实业100%股权｜医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2633512166","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633512166?lang=zh_cn&edition=fundamental","pubTime":"2026-05-07 07:00","pubTimestamp":1778108408,"startTime":"0","endTime":"0","summary":"丨2026年5月7日星期四丨NO.1时安生物与GSK就寡核苷酸新药达成超10亿美元授权合作时安生物宣布，与葛兰素史克（GSK）就SA030达成一项中国市场以外的全球独家许可协议。葛兰素史克将支付首付款，以及未来基于成功达成的开发、注册与商业化里程碑付款，总额最高达10.05亿美元；同时将按中国以外的全球产品净销售额支付分级特许权使用费。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605073729101163.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605073729101163.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","GSK.UK","BK1161","BK0239","BK4007","GSK","BK1574","BK4588","09939","LU1829250122.USD","BK4585","GSKH","159938","603168","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631440005","title":"葛兰素史克(GSK)股票4月29日盘中下跌5.22%：关键驱动因素揭晓","url":"https://stock-news.laohu8.com/highlight/detail?id=2631440005","media":"TradingKey中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631440005?lang=zh_cn&edition=fundamental","pubTime":"2026-04-30 01:17","pubTimestamp":1777483043,"startTime":"0","endTime":"0","summary":"• 尽管销售强劲并重申了业绩指引，GSK股价仍出现下跌。\n• 每股收益低于分析师预期，引发了市场的负面反应。\n• 法律拨备及对老牌药物的担忧影响了投资者信心。","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/261838095-market-movers-gsk-20260429","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GSK.UK","GSKH","GSK","LU1829250122.USD","BK4585","BK4532","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631910535","title":"英国头部药企利润意外大增，尽管行业受美国政策冲击","url":"https://stock-news.laohu8.com/highlight/detail?id=2631910535","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631910535?lang=zh_cn&edition=fundamental","pubTime":"2026-04-29 18:15","pubTimestamp":1777457700,"startTime":"0","endTime":"0","summary":"英国两大药企阿斯利康与葛兰素史克周三公布 2026 年一季度核心盈利均超预期，开局向好。欧洲多家药企高管近期警示：特朗普政府推行最惠国待遇药价政策，将美国药价与他国低价挂钩，欧洲或面临新药上市减少的风险。　　英国市值第二大公司阿斯利康与第九大公司葛兰素史克周三早盘公布一季度利润，双双超出市场预期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-29/doc-inhwefuw7976588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1829250122.USD","GSK.UK","GSKH","BK4007","BK4585","BK4532","BK4588","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129840658","title":"葛兰素史克Q1业绩超市场预期，预计全年盈利增长7%至9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1129840658","media":"老虎资讯综合","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129840658?lang=zh_cn&edition=fundamental","pubTime":"2026-04-29 14:09","pubTimestamp":1777442988,"startTime":"0","endTime":"0","summary":"4月29日，$葛兰素史克(GSK)$盘后一度涨超6%，随后快速回落！该公司第一季度营收76.3亿英镑，预估76.1亿英镑；第一季度调整后每股收益46.5便士，预估43.2便士。预计全年销售额（按固定汇率计算）增长3%至5%；预计全年调整后每股收益增长7%至9%；预计全年调整后营业利润增长7%至9%；预计2031年销售额将超过400亿英镑。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ca0e3dea87604e6a95a3bf5695c5bcab","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"葛兰素史克Q1业绩超市场预期，预计全年盈利增长7%至9%","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225771236.USD","LU0987226296.USD","LU0985481810.HKD","LU1645745479.HKD","LU0225284248.USD","LU1035777561.USD","LU1309081286.SGD","LU1228905037.USD","IE00B3T34201.USD","LU0211331839.USD","LU0306807586.USD","LU1400636574.HKD","LU1829250122.USD","LU2646069778.SGD","LU0109981661.USD","LU0161305163.EUR","IE0034235071.USD","LU0575583348.USD","LU1015430645.USD","LU1202635105.USD","LU0321505868.SGD","BK4588","GSK","LU1400636491.USD","LU1098665638.USD","LU0545562505.USD","LU1228905540.USD","LU0557290698.USD","LU1670756490.USD","LU0971552830.HKD","LU1400636657.SGD","IE00BWDBJ516.SGD","LU1302929846.USD","BK4007","LU1064927863.SGD","LU0289739699.SGD","LU0306806265.USD","BK4532","LU1487256676.USD","LU1481600234.SGD","LU0225283273.USD","SG9999001176.SGD","BK4585","IE00BQJZX424.USD","LU1481599808.USD","LU0971552673.USD","LU1046248800.SGD","LU1983299246.USD","LU0203345920.USD","SG9999001176.USD","BK5011","LU0321505439.SGD","LU0203347892.USD","SGXZ57979304.SGD","GSKH","SG9999013999.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630393046","title":"从“抗艾第一股”到小核酸新贵 前沿生物股价与业绩齐飞 靠GSK千万美元授权金逆势涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2630393046","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630393046?lang=zh_cn&edition=fundamental","pubTime":"2026-04-27 18:46","pubTimestamp":1777286760,"startTime":"0","endTime":"0","summary":"4月27日，在医药股普遍承压、板块整体走弱的背景下，创新药企前沿生物（688221.SH）却逆势爆发，开盘后快速拉升触及20%的涨停板，截至收盘，前沿生物涨停封板，报22.74元/股。前沿生物成立于2003年，创始人谢东出生于1966年，曾领导和参与了多个艾滋病新药的全球开发与上市工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604273720433081.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604273720433081.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1829250122.USD","GSK.UK","BK4588","688221","GSK","BK0239","BK4007","BK4532","BK4585","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628064279","title":"葛兰素史克(GSK.US)Belantamab mafodotin(玛贝兰妥单抗)在华获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2628064279","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628064279?lang=zh_cn&edition=fundamental","pubTime":"2026-04-17 16:39","pubTimestamp":1776415186,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月17日，国家药监局(NMPA)网站显示，葛兰素史克(GSK.US)的Belantamab mafodotin(玛贝兰妥单抗)在华获批上市。根据此前的优先审评信息，此次获批的适应症为联合硼替佐米和地塞米松治疗既往接受过至少一种治疗的多发性骨髓瘤成人患者。玛贝兰妥单抗是Seagen(已被辉瑞收购)开发的一款BCMA ADC。2009年12月，GSK与Seagen达成协议，获得该药物的研究、开发、生产和商业化权益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429939.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GSK","BK4585","LU1829250122.USD","GSKH","BK4588","GSK.UK","IPOS","BK4007","BK4532"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":5,"totalSize":91,"code":"91000000","status":"200"}]}}